In addition to monitoring warfarin therapy, the prothrombin time (PT) and activated partial prothrombin time (aPTT) tests will help in the determination of factor deficiencies and other coagulopathies in several point-of-care locations.
The enhanced connectivity options allow for immediate access to patients’ data via their electronic health records because wireless technology ensures fast, accurate transmission so that workflow will be more streamlined and results will be available for immediate treatment decisions.
More efficiency in my care facility. More freedom for my patients
A variety of models exists for managing patients of VKA therapy. Learn more about the benefits of point of care and patient self-testing and how we can support you in selecting the right model for you and your patients.